In vitro activity of eravacycline against common ribotypes of Clostridioides difficile

BACKGROUND: Eravacycline is a novel synthetic fluorocycline antibacterial approved for complicated intra-abdominal infections. OBJECTIVES: The purpose of this study was to assess the in vitro activities of eravacycline and comparator antibiotics against contemporary clinical isolates of Clostridioid...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Antimicrob Chemother
Päätekijät: Bassères, Eugénie, Begum, Khurshida, Lancaster, Chris, Gonzales-Luna, Anne J, Carlson, Travis J, Miranda, Julie, Rashid, Tasnuva, Alam, M Jahangir, Eyre, David W, Wilcox, Mark H, Garey, Kevin W
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678891/
https://ncbi.nlm.nih.gov/pubmed/32719870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa289
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia